TickerFactsScreenerDevelopers

Lineage Cell Therapeutics, Inc. (LCTX) — EPS (Diluted)

Annual figures by fiscal year, from SEC filings.

2014: $-0.552015: $-0.592016: $0.352017: $-0.172021: $-0.262022: $-0.152023: $-0.122024: $-0.092025: $-0.28$-0.28
2014EPS (Diluted) (USD/shares)2025
Fiscal YearEPS (Diluted)Change YoY
2025$-0.28-211.1%
2024$-0.09+25.0%
2023$-0.12+20.0%
2022$-0.15+42.3%
2021$-0.26—
2017$-0.17-148.6%
2016$0.35+159.3%
2015$-0.59-7.3%
2014$-0.55—